IP Library Granted Patent US 9,683,028
Granted Patent B2
US 9,683,028 · App. 14/557,171 · Granted Jun 20, 2017

Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,683,028
App. No.
14/557,171
Granted
Jun 20, 2017
Kind
B2
Abstract

Methods useful in constructing libraries that collectively display and/or express members of diverse families of peptides, polypeptides or proteins and the libraries produced using those methods. Methods of screening those libraries and the peptides, polypeptides or proteins identified by such screens.

Claims (20)

1. A vector comprising: (i) a DNA sequence encoding an antibody variable region linked to a fragment of a wild-type pIII anchor, which does not mediate infection of phage particles; and (ii) a wild-type gene III; wherein the nucleic acid sequence encoding the fragment of the wild-type pIII anchor in (i) differs from the portion of the wild-type gene III encoding the same fragment to an extent sufficient to reduce homologous recombination between the nucleic acid encoding the fragment of the wild-type PIII anchor in (i) and the wild-type gene III in (ii).

2. The vector of claim 1 , wherein the DNA sequence set forth in (i) encodes a Fab or a single chain Fv (scFv).

3. The vector of claim 1 , wherein the DNA sequence set forth in (i) encodes heavy chain VHCH1 or light chain VLCL.

4. The vector of claim 3 , wherein either the heavy chain VHCH1 or the light chain VLCL is linked to trpIII.

5. The vector of claim 3 , wherein the DNA sequence set forth in (i) encodes light chain VLCL.

6. The vector of claim 5 , wherein the light chain VLCL is linked to trpIII.

7. The vector of claim 2 , wherein the DNA sequence set forth in (i) encodes scFv.

8. The vector of claim 7 , wherein the scFv is VL-VH.

9. The vector of claim 7 , wherein the scFv is VH-VL.

10. The vector of claim 1 , wherein the DNA sequence encoding the antibody variable region further comprises an inducible promoter.

11. The vector of claim 10 , wherein the inducible promoter regulates expression of the DNA sequence encoding the antibody variable region.

12. The vector of claim 1 , wherein the DNA sequence encoding the antibody variable region further comprises an amber stop codon.

13. The vector of claim 12 , wherein the amber stop codon is located between the antibody variable region and the fragment of the wild-type pIII anchor.

14. The vector of claim 1 , wherein the vector is phage or phagemid.

15. The vector of claim 1 , wherein the vector further comprises a wild-type gene VIII.

16. The vector of claim 2 , wherein the DNA sequence set forth in (i) encodes a Fab.

17. The vector of claim 3 , wherein the DNA sequence set forth in (i) encodes heavy chain VHCH1.

18. The vector of claim 17 , wherein the heavy chain VHCH1 is linked to trpIII.

19. The vector of claim 17 , wherein the heavy chain VHCH1 is of an IgG or an IgM.

20. The vector of claim 18 , wherein the DNA sequence set forth in (i) further encodes light chain VLCL.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2015
From: LADNER, ROBERT C.; COHEN, EDWARD H.; NASTRI, HORACIO G.; ROOKEY, KRISTIN L.; HOET, RENE; HOOGENBOOM, HENDRICUS RENERUS JACOBUS MATTHEUS
To: DYAX CORP.
Reel/Frame 035848/0166 →